{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:14:04Z","timestamp":1698736444644},"reference-count":8,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T00:00:00Z","timestamp":1349308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/pace.12004","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T21:11:16Z","timestamp":1349385076000},"page":"1409-1410","source":"Crossref","is-referenced-by-count":1,"title":["Augmentation\/Attenuation of the QRST Complexes and Their Effects on the QT\/QTc: A Heretofore Overlooked Important Association"],"prefix":"10.1111","volume":"35","author":[{"given":"JOHN E.","family":"MADIAS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,10,4]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02367-6"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.09384.x"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.00221.x"},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2000.tb00736.x"},{"key":"e_1_2_2_6_2","article-title":"\u201cHeart rate\u2010dependent\u201d electrocardiographic diagnosis of left ventricular hypertrophy","author":"Madias JE","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.35.3.288"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-0736(90)90150-Z"},{"key":"e_1_2_2_9_2","unstructured":"Guidance for Industry: E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non\u2010Antiarrhythmic Drugs. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Rockville MD Food and Drug Administration; October 2005. Available at:http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/ucm129357.pdf(accessed May 7 2012)."}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpace.12004","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pace.12004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T17:05:51Z","timestamp":1698685551000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pace.12004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,4]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/pace.12004"],"URL":"https:\/\/doi.org\/10.1111\/pace.12004","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,4]]}}}